ASKA Pharmaceutical Holdings Co., Ltd. Financial Overview
ASKA Pharmaceutical Holdings Co., Ltd.'s market cap is currently ¥54.24B. The company's EPS TTM is ¥34.61; its P/E ratio is 12.13; and it has a dividend yield of 2.55%. ASKA Pharmaceutical Holdings Co., Ltd. is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
